Home
Conditions
Neoplasms, Plasma Cell

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

512 public trials 52 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Completed

Safety Study Looking at the Use of a Natural Killer Cell Line Against Hematological Malignancies

NCT00990717

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations: Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Combination of Lenalidomide and Autologous Mature Dendritic Cells Pulsed With KRN7000 in Myeloma

NCT00698776

Conditions: Myeloma, Neoplasms, Neoplasms by Histologic Type, +1 more
Locations: Yale University School of Medicine New Haven, Connecticut, United States

View Trial Details

Completed

Lenalidomide and High-Dose Melphalan

NCT01079936

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies

NCT00410982

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +19 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Investigation of the Enhancement of Response to Hepatitis B Vaccine by Lenalidomide in Plasma Cell Dyscrasias

NCT02041325

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Plasma Cell, +1 more
Locations: VA Boston Healthcare System Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis

NCT00477971

Conditions: Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Melphalan, Prednisone, Thalidomide and Defibrotide in Relapsed Multiple Myeloma Patients

NCT00406978

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Dip. Scienze Mediche & IRCAD-Università, UDA Ematologia Novara, Italy

Policlinico Monteluce, Clinica Medica I Perugia, Italy

Divisione Di Ematologia, Ospedali Riuniti Reggio Calabria, Italy

Servizio di Ematologia, Azienda Ospedaliera S. Maria Nuova Reggio Emilia, Italy

View Trial Details

Completed

Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant

NCT01904175

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +19 more
Locations: Duke University Health System Durham, North Carolina, United States

View Trial Details

Completed

Trial of Carfilzomib Plus Melphalan and Prednisone in Elderly Untreated Patients With Multiple Myeloma (CARMYSAP)

NCT01279694

Conditions: Myeloma, Neoplasms, Neoplasms by Histologic Type, +1 more
Locations: CHU de Nantes Nantes, France

View Trial Details

Completed

Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant

NCT00293384

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +112 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Neoplasms, Plasma Cell

Neoplasms, Plasma Cell trial results

Related conditions